In November, the public learned of the results of Pfizer's phase 3 trial of its COVID-19 vaccine, demonstrating the vaccine was highly effective and safe among the then 38,955 people who had received both doses.

Now, more than two months after the first vaccine dose was administered in Connecticut, people who have received both doses are not just unnamed data points but members of your community — your family members, friends, neighbors, co-workers and medical providers.

We're interested in sharing the experiences of people who live and/or work in Connecticut and have received both doses of the Pfizer or Moderna vaccine. We're interested in hearing about whether the initial feeling was one of excitement or hesitation, side effects and conversations had about the vaccine.

If you want to share, please fill out our survey at theday.com/vaccinesurvey. Or, if you don't use computers, feel free to leave a voicemail for reporter Erica Moser at (860) 701-4489.